The post Huajian Medical Suspends $410 Million ETH Acquisition Plan appeared on BitcoinEthereumNews.com. Key Points: Huajian Medical halts its $410 million ETH acquisition due to delayed shareholder authorization. Market strategies impacted, leading to a suspension in plans. Future purchases will comply with Hong Kong’s listing rules. Huajian Medical, a Hong Kong-listed company, has temporarily suspended its plan to purchase ETH worth approximately 3 billion yuan due to shareholder authorization delays as announced by the Hong Kong Stock Exchange. The pause underscores challenges in executing large-scale cryptocurrency acquisitions within regulated markets, potentially impacting Huajian’s strategic asset tokenization and AI platform integration efforts. Huajian Medical Halts $410 Million Ethereum Acquisition Huajian Medical, a Hong Kong-listed entity, recently paused its planned acquisition of Ethereum worth 3 billion yuan. The company aimed to finalize shareholder authorization but needed additional time to secure it, leading to a temporary suspension. The company will adhere to listing rules set by the Hong Kong Stock Exchange, ensuring that any significant purchases are properly disclosed. This reflects their ongoing commitment to regulatory compliance and transparency. No official comments from major crypto figures or stakeholders have emerged regarding this suspension. According to an official source, “Future ETH purchases will be publicly disclosed per Chapter 14 of the HK listing rules.” Market observers note the impact on Huajian’s stock performance following its announcement of digital asset strategies earlier in the year. Traditional Corporations Eyeing Ethereum Amid Regulatory Changes Did you know? Huajian Medical’s move illustrates an increasing trend where traditional companies explore Ethereum amidst evolving digital asset regulations in Hong Kong. According to CoinMarketCap, Ethereum (ETH) is priced at $3,868.25, with a market cap of $466.89 billion, holding a 12.59% market dominance. Recent trends reveal the crypto’s 24-hour volume fell by 18.71%, with a 5.93% rise over 90 days. Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 15:33 UTC on November 2, 2025. Source: CoinMarketCap… The post Huajian Medical Suspends $410 Million ETH Acquisition Plan appeared on BitcoinEthereumNews.com. Key Points: Huajian Medical halts its $410 million ETH acquisition due to delayed shareholder authorization. Market strategies impacted, leading to a suspension in plans. Future purchases will comply with Hong Kong’s listing rules. Huajian Medical, a Hong Kong-listed company, has temporarily suspended its plan to purchase ETH worth approximately 3 billion yuan due to shareholder authorization delays as announced by the Hong Kong Stock Exchange. The pause underscores challenges in executing large-scale cryptocurrency acquisitions within regulated markets, potentially impacting Huajian’s strategic asset tokenization and AI platform integration efforts. Huajian Medical Halts $410 Million Ethereum Acquisition Huajian Medical, a Hong Kong-listed entity, recently paused its planned acquisition of Ethereum worth 3 billion yuan. The company aimed to finalize shareholder authorization but needed additional time to secure it, leading to a temporary suspension. The company will adhere to listing rules set by the Hong Kong Stock Exchange, ensuring that any significant purchases are properly disclosed. This reflects their ongoing commitment to regulatory compliance and transparency. No official comments from major crypto figures or stakeholders have emerged regarding this suspension. According to an official source, “Future ETH purchases will be publicly disclosed per Chapter 14 of the HK listing rules.” Market observers note the impact on Huajian’s stock performance following its announcement of digital asset strategies earlier in the year. Traditional Corporations Eyeing Ethereum Amid Regulatory Changes Did you know? Huajian Medical’s move illustrates an increasing trend where traditional companies explore Ethereum amidst evolving digital asset regulations in Hong Kong. According to CoinMarketCap, Ethereum (ETH) is priced at $3,868.25, with a market cap of $466.89 billion, holding a 12.59% market dominance. Recent trends reveal the crypto’s 24-hour volume fell by 18.71%, with a 5.93% rise over 90 days. Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 15:33 UTC on November 2, 2025. Source: CoinMarketCap…

Huajian Medical Suspends $410 Million ETH Acquisition Plan

2025/11/02 23:40
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다
Key Points:
  • Huajian Medical halts its $410 million ETH acquisition due to delayed shareholder authorization.
  • Market strategies impacted, leading to a suspension in plans.
  • Future purchases will comply with Hong Kong’s listing rules.

Huajian Medical, a Hong Kong-listed company, has temporarily suspended its plan to purchase ETH worth approximately 3 billion yuan due to shareholder authorization delays as announced by the Hong Kong Stock Exchange.

The pause underscores challenges in executing large-scale cryptocurrency acquisitions within regulated markets, potentially impacting Huajian’s strategic asset tokenization and AI platform integration efforts.

Huajian Medical Halts $410 Million Ethereum Acquisition

Huajian Medical, a Hong Kong-listed entity, recently paused its planned acquisition of Ethereum worth 3 billion yuan. The company aimed to finalize shareholder authorization but needed additional time to secure it, leading to a temporary suspension.

The company will adhere to listing rules set by the Hong Kong Stock Exchange, ensuring that any significant purchases are properly disclosed. This reflects their ongoing commitment to regulatory compliance and transparency.

No official comments from major crypto figures or stakeholders have emerged regarding this suspension. According to an official source, “Future ETH purchases will be publicly disclosed per Chapter 14 of the HK listing rules.” Market observers note the impact on Huajian’s stock performance following its announcement of digital asset strategies earlier in the year.

Traditional Corporations Eyeing Ethereum Amid Regulatory Changes

Did you know? Huajian Medical’s move illustrates an increasing trend where traditional companies explore Ethereum amidst evolving digital asset regulations in Hong Kong.

According to CoinMarketCap, Ethereum (ETH) is priced at $3,868.25, with a market cap of $466.89 billion, holding a 12.59% market dominance. Recent trends reveal the crypto’s 24-hour volume fell by 18.71%, with a 5.93% rise over 90 days.

Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 15:33 UTC on November 2, 2025. Source: CoinMarketCap

The Coincu research team notes that Huajian’s suspension may hint at growing caution within the industry to navigate regulatory landscapes. These dynamics underscore the balance companies must maintain between innovation and compliance.

Source: https://coincu.com/news/huajian-eth-acquisition-delay/

시장 기회
이더리움 로고
이더리움 가격(ETH)
$2,388.99
$2,388.99$2,388.99
+1.75%
USD
이더리움 (ETH) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

Roll the Dice & Win Up to 1 BTC

Roll the Dice & Win Up to 1 BTCRoll the Dice & Win Up to 1 BTC

Invite friends & share 500,000 USDT!